Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Agile Therapeutics, Inc.

NASDAQ: AGRXHealthcare / Drugs - Generic / USA
0.8900+0.1100+14.10%Vol 691 7431Y Perf -74.61%
Jan 18th, 2019 16:00
BID0.8500 ASK0.9000
Open0.7800 Previous Close0.7800
Pre-Market- After-Trading0.89
 - -%  - -%
Target Price
3.13 
Analyst Rating
Moderate Buy 1.67
Potencial %
251.69 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)31 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
17.89 
Earnings Date
11th Mar 2019

Today's Price Range

0.78000.8900

 

52wk Range

0.23003.92

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
41.27%
3 Months
-7.29%
6 Months
74.51%
1 Year
-74.61%
3 Years
-87.72%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
AGRX0.89000.110014.10
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.00
Current Ratio
2.10
Long Term Debt to Total Capital
0.12
Total Debt to Equity
0.25
Interest Coverage
-15.60
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.16
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.90
Cash Flow Per Share
-0.57
Price to Tangible Book
1.16
Book Value per Share
0.67
Enterprise Value (in ths.)
15 800
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-462.75
ROE last 12 Months
-68.60
Return on Assets (5Y Avg)
-52.35
ROA last 12 Months
-49.35
Return on Capital (5Y Avg)
-47.27
ROC last 12 Months
-55.31
Return on invested Capital Q
-11.51
Return on invested Capital Y
-56.55
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-0.1126.67
Q02 2018-0.17-0.165.88
Q01 2018-0.19-0.21-10.53
Q04 2017-0.23-0.1821.74
Q03 2017-0.25-0.2212.00
Q02 2017-0.28-0.267.14
Q01 2017-0.31-0.2616.13
Q04 2016-0.27-0.29-7.41
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.127.69Positive
12/2018 FY-0.597.81Positive
3/2019 QR-0.1378.33Positive
12/2019 FY-0.57--
Next Report Date11th Mar 2019
Estimated EPS Next Report-0.12
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume691 743
Shares Outstanding (in ths.)34 377
Trades Count990
Dollar Volume574 110
Avg. Volume242 517
Avg. Weekly Volume256 405
Avg. Monthly Volume258 766
Avg. Quarterly Volume1 023 107

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

59%41%

Bearish Bullish

64%36%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
2.33

There are no comments yet.

News